Cookie Use Notification

This site uses cookies to provide you with a more responsive and personalised service.

By using this site you agree to our use of cookies as set out in our cookie notice. Please read our cookie notice for more information on the cookies we use and how to delete or block the use of cookies.

Life Science: Great Promise & Rapid Growth

Download Report Charts & Graphs

According to Cushman & Wakefield's February 2019 report, the life science industry is emerging as one of the fastest-growing sectors in the U.S. economy, with many characteristics that appear recession resistant. Where technology combines with healthcare, life science has become a broad and growing sector of the economy that encompasses everything from genetic engineering to medical device technology to pharmaceutical research and development, and much more.

In this report, Cushman & Wakefield has analyzed key economic, demographic, and real estate-related data for the following 13 top life science markets in the U.S. and Canada:

The report delves into these four key takeaways and more:

  • Explosive growth in the 65-and-older population has created rising demand for drugs, therapies and medical devices to extend and improve quality of life
  • During the past three recessionary periods, employment in the life science sector far outperformed total employment along with key sectors including technology
  • Venture capital funding targeting life science has steadily grown since 2010, with Boston ranking as the #1 metro for VC funding between 2010 and 2018 at $15.5 billion
  • In key life science markets, the inventory of lab space is rising twice as fast as the overall office inventory, but high demand is keeping vacancy rates very low